Management of Infant Digestive Disorders and Quality of Life
NCT ID: NCT04462640
Last Updated: 2022-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
101 participants
OBSERVATIONAL
2020-08-28
2021-11-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Probiotics Supplementation in Premature Infants
NCT01379417
Evolution of Functional Gastrointestinal Disorders in Infants Fed With a New Infant Formula
NCT06488274
Gut Bacteria and Brain of the Baby
NCT04432636
Safety and Efficacy of Infant Formulas Supplemented With Pre- and Probiotic(s)
NCT04962594
Study in Unsettled Infants Experiencing Feeding Intolerance
NCT02021058
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
regurgitation
45 infants aged 0 to 5 months suffering from regurgitation
Management of Infant Digestive Disorders and Quality of Life
The variation of the QUALIN score on D30 compared to inclusion (D0) will be described and compared using a Student test for paired data in the case of a normal distribution or a test of the ranks signed by Wilcoxon otherwise.
colic
45 infants aged 0 to 5 months suffering from colic
Management of Infant Digestive Disorders and Quality of Life
The variation of the QUALIN score on D30 compared to inclusion (D0) will be described and compared using a Student test for paired data in the case of a normal distribution or a test of the ranks signed by Wilcoxon otherwise.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Management of Infant Digestive Disorders and Quality of Life
The variation of the QUALIN score on D30 compared to inclusion (D0) will be described and compared using a Student test for paired data in the case of a normal distribution or a test of the ranks signed by Wilcoxon otherwise.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infants with regurgitation and / or colic defined according to Rome IV criteria
* Non-breastfed infants
* Parents who understand and speak French fluently
* Parents agreeing to send their email address and having a computer tool (computer, tablet or smartphone) allowing them to complete the QoL questionnaires and the satisfaction questionnaire
* Parents having understood the protocol and the information given and having given the participation agreement including their acceptance to return for consultation with the same doctor after a period of 30 days.
Exclusion Criteria
• Intercurrent pathology other than a functional intestinal disorder which can by themselves cause, directly or as a result of treatments, a functional intestinal disorder: Study Management of infant digestive disorders and Quality of life
* Food allergy
* Digestive pathology (Gastroenteritis, celiac disease, high or low digestive malformations….)
* Heart failure, cyanogenic heart disease
* Chronic respiratory diseases (bronchopulmonary dysplasia, malformations, respiratory failure)
* Neurological pathologies (Cerebral palsy, intracranial hypertension, convulsive state)
* Congenital metabolic pathologies
* Genetic diseases
* Kidney malformations, Vesicoureteral reflux, Kidney failure.
* Drug treatment in progress and which will be continued during the study, other than vitamins (D, K, ...)
* Partial or total breastfeeding
* Infants already fed:
* with a hypoallergenic formula (HA)
* or with a high hydrolyzate of cow's milk proteins or formula based on rice protein hydrolyzate
* Growth retardation (weight and or height less than or equal to - 2 DS) or break in the weight curve (no weight gain or weight loss in the past month) Prescription of drugs or food supplements other than vitamins at the end of the visit
1 Week
4 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Keyrus Biopharma
OTHER
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sandra Brancato
Brignon, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chouraqui JP, Brancato S, Delmas B, Hanh T. Effectiveness of a starch thickened infant formula with reduced lactose content, probiotics and prebiotics on quality of life and clinical outcome in infants with regurgitation and/or colic. Front Nutr. 2023 May 25;10:1164722. doi: 10.3389/fnut.2023.1164722. eCollection 2023.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A03340-57
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.